Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients
The DOI matches its Crossref record.
Abstract
BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) [also called drug-induced hypersensitivity syndrome (DIHS)] includes severe reactions to drugs that need to be promptly recognized by physicians. AIM: To explore heterogeneity in the clinical presentation of DRESS/DIHS at a large academic hospital in Latin America, using the criteria defined by the European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) scoring system. METHODS: A retrospective medical record review of 60 patients with diagnostic suspicion of DRESS/DIHS admitted to our hospital between July 2008 and April 2012 was performed, including demographic data, clinical features, laboratory findings and treatment. RESULTS: Of the 60 patients, 27 fulfilled the criteria for DRESS/DIHS. Maculopapular exanthema (85.1%), fever (96.2%) and hepatic involvement (85.1%) were the most common features. Anticonvulsants were the most common causal drugs (77.7%); Phenytoin was the most common individual drug (44.4%), followed by carbamazepine (29.6%). All patients were treated initially with prednisone 1 mg/kg/day. Mortality rate was 4%. CONCLUSION: The major findings of this study (to our knowledge the largest collection of data on DRESS/DIHS in Latin America) include a positive statistical association between presence of atypical lymphocytes and higher levels of alanine aminotransferase (P < 0.001) and reinforce the importance of anticonvulsants in the pathogenesis of this severe reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Methylprednisolone at a dose of 1 mg/kg is frequently given to patients with severe immune-mediated hypersensitivity reactions, including the drug reaction with eosinophilia and systemic symptoms (DRESS) [46].”
From Drug-induced liver injury. Part I: Classification, diagnosis and treatment (2025) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- Bocquet, 1996, Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS), Semin Cutan Med Surg, 15, 250, 10.1016/S1085-5629(96)80038-1 · DOI · Paper page
- Walsh, 2011, Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking, Clin Exp Dermatol, 36, 6, 10.1111/j.1365-2230.2010.03967.x · DOI · Paper page
- Chaiken, 1950, Dilantin sensitivity: report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis, N Engl J Med, 242, 897, 10.1056/NEJM195006082422304 · doi:10.1056/nejm195006082422304
- Roujeau, 1994, Severe adverse cutaneous reactions to drugs, N Engl J Med, 331, 1272, 10.1056/NEJM199411103311906 · DOI · Paper page
- Peyriere, 2006, Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, Br J Dermatol, 155, 422, 10.1111/j.1365-2133.2006.07284.x · DOI · Paper page
- Eshki, 2009, Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure, Arch Dermatol, 145, 67, 10.1001/archderm.145.1.67 · DOI · Paper page
- Shear, 1988, Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk, J Clin Invest, 82, 1826, 10.1172/JCI113798 · DOI · Paper page
- Vittorio, 1995, Anticonvulsant hypersensitivity syndrome, Arch Intern Med, 155, 2285, 10.1001/archinte.1995.00430210033005 · doi:10.1001/archinte.1995.00430210033005 · Paper page
- Gentile, 2010, Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review, BMC Infect Dis, 10, 49, 10.1186/1471-2334-10-49 · DOI · Paper page
- Criado, 2012, Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts, An Bras Dermatol, 87, 435, 10.1590/S0365-05962012000300013 · DOI · Paper page
- Shiohara, 2007, The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations, Br J Dermatol, 156, 1083, 10.1111/j.1365-2133.2007.07807.x · DOI · Paper page
- Bohan, 2007, Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care, Pharmacotherapy, 27, 1425, 10.1592/phco.27.10.1425 · doi:10.1592/phco.27.10.1425
- Sullivan, 2001, The drug hypersensitivity syndrome: what is the pathogenesis?, Arch Dermatol, 137, 357
- Cacoub, 2011, The DRESS syndrome: a literature review, Am J Med, 124, 588, 10.1016/j.amjmed.2011.01.017 · DOI · Paper page
- Um, 2010, Clinical features of drug-induced hypersensitivity syndrome in 38 patients, J Investig Allergol Clin Immunol, 20, 556
- Chen, 2010, Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases, Arch Dermatol, 146, 1373, 10.1001/archdermatol.2010.198 · DOI · Paper page
- Kardaun, 2007, Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, Br J Dermatol, 156, 609, 10.1111/j.1365-2133.2006.07704.x · DOI · Paper page
- Ang, 2010, Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients, J Am Acad Dermatol, 63, 219, 10.1016/j.jaad.2009.08.050 · DOI
- Sontheimer, 1998, DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome, Arch Dermatol, 134, 874, 10.1001/archderm.134.7.874 · doi:10.1001/archderm.134.7.874
- Shiohara, 2006, Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses, Allergol Int, 55, 1, 10.2332/allergolint.55.1 · DOI · Paper page
- Husain, 2013, DRESS syndrome: part I. Clinical perspectives, Am Acad Dermatol, 68, 693, 10.1016/j.jaad.2013.01.032 · DOI · Paper page
- Lee, 2008, Drug Rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs, J Korean Med Sci, 23, 521, 10.3346/jkms.2008.23.3.521 · doi:10.3346/jkms.2008.23.3.521
- Kano, 2010, Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome, Med Clin North Am, 94, 743, 10.1016/j.mcna.2010.03.004 · DOI
- Criado, 2002, Síndrome de hipersensibilidade a anticonvulsivantes: relato de dois casos, Rev Bras Clin Terap, 28, 59
- Husain, 2013, DRESS syndrome: part II. Management and therapeutics, J Am Acad Dermatol, 68, 709, 10.1016/j.jaad.2013.01.032 · DOI · Paper page
- Kano, 2006, Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease, Br J Dermatol, 155, 301, 10.1111/j.1365-2133.2006.07238.x · doi:10.1111/j.1365-2133.2006.07238.x
- Uhara, 2013, Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids, J Eur Acad Dermatol Venereol, 27, 722, 10.1111/j.1468-3083.2012.04547.x · doi:10.1111/j.1468-3083.2012.04547.x
Cited by
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
“[150] Corticosteroids at a dose of 1 mg/kg of methylprednisolone are frequently given to patients with severe immune‐mediated hypersensitivity reactions, including the syndrome known as drug reaction with eosinophilia and systemic symptoms (DRESS).[151,152] In some instances, a short course of corticosteroids (i.”
BackgroundStine, J. G., & Lewis, J. H. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1127756 · Cited by 104
Mazzanti, G., Moro, P. A., Raschi, E., Da Cas, R., & Menniti‐Ippolito, F. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13171 · Cited by 81
Drug-induced liver injury: Highlights from a review of the 2015 literature
Sarges, P., Steinberg, J. M., & Lewis, J. H. (2016) · Drug Safety · doi:10.1007/s40264-016-0427-8 · Cited by 74
Drug-induced liver injury. Part I: Classification, diagnosis and treatment
Kozielewicz, D. M., Stalke, P., & Skrzypek, J. (2025) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2025.148329 · Cited by 19
“Methylprednisolone at a dose of 1 mg/kg is frequently given to patients with severe immune-me-Clinical diated hypersensitivity reactions, including the drug reaction with eosinophilia and systemic symptoms (DRESS) [46].”
Metadata
- Authors
- Avancini, J., Maragno, L., Santi, C. G., & Criado, P. R.
- Affiliations
- Department of Dermatology; University of São Paulo; São Paulo Brazil
- Venue
- Clinical and Experimental Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-14
- Volume
- 40
- Issue
- 8
- Pages
- 851-859
- ISSN
- 0307-6938
- Cited by
- 51
- References
- 0
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 18 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients. https://app.cochat.ai/papers/10.1111/ced.12682
- The paper
- Avancini, J., Maragno, L., Santi, C. G., & Criado, P. R. (2015). Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients. Clinical and Experimental Dermatology. https://doi.org/10.1111/ced.12682
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.